Shares were hovering around one dollar when the FDA sent out this quiet signal on their new tumor drug.
Within six months, shares shot up 845% ... | Caladrius Biosciences' stock was going nowhere, stuck around $4 ...
Then it got this FDA signal.
And shares jumped 119% - in two days. | Ocugen received an FDA signal in December 2023.
Its share price spiked 435% in just five months.
63 different publicly traded companies have received 76 of these signals between them in the last seven years.
We examined every single one.
97% of them saw the stock price go up in the aftermath.
And now, we believe the next FDA signal could come any day ...
Perhaps as soon as 9:30 a.m. tomorrow.
Click here to find out how you can get in before the FDA's potential signal. | | |
Editor's Note: Above is an important message from one of our highly valued sponsors. Please read it carefully as they have some special information to share with you. |
No comments:
Post a Comment